Common Lower Urinary Tract Symptoms Research Articles

Association between family income to poverty ratio and nocturia in adults aged 20 years and older: A study from NHANES 2005-2010.

Nocturia, the most common lower urinary tract symptom (LUTS), significantly impacts socioeconomic factors and individuals' quality of life and is closely related to many diseases. This study utilized data from NHANES 2005-2010 to explore the relationship between family income to poverty ratio (PIR) and the presence of nocturia symptoms in adults aged 20 or older in the United States. Data from the National Health and Nutrition Examination Survey (NHANES) in 2005-2010, including 6,662 adults aged 20 or older, were utilized for this cross-sectional study. The baseline data was used to display the distribution of each characteristic visually. Multiple linear regression and smooth curve fitting were used to study the linear and non-linear correlations between PIR and nocturia. Subgroup analysis and interaction tests were conducted to examine the stability of intergroup relationships. Out of the 6,662 adult participants aged 20 or older, 1,300 households were categorized as living in poverty, 3,671 households had a moderate income, and 1,691 households were classified as affluent. Among these participants, 3,139 individuals experienced nocturia, representing 47.12% of the total, while 3,523 individuals were nocturia-free, constituting 52.88% of the total population. After adjusting for all other covariates, it was found that PIR was significantly negatively correlated with nocturia (OR: 0.875, 95%CI: 0.836-0.916 P<0.0001). This trend persisted when PIR was divided into three groups (PIR <1, PIR 1-4, PIR > 4) or quartiles. There was a non-linear negative correlation between PIR and nocturia. Our findings indicated that lower PlR was associated with a higher risk of nocturia in adults aged 20 or older in the United States. These findings highlight the importance of considering socioeconomic factors in preventing and managing nocturia. Nonetheless, further exploration of the causal nexus between these factors was precluded due to the constraints of a cross-sectional design.

Prostate specific antigen in the serum of men ≥ 50 years old with benign prostatic hyperplasia and some related factors

Background: Men over 50 years old often have lower urinary tract symptoms and most of them are caused by benign prostatic hyperplasia (BPH). The incidence of benign prostatic hyperplasia increases with age. Besides benign prostate disease, the incidence of prostate cancer is increasing in Vietnam and ranks 7th according to GLOBOCAN 2020 estimates. Recognizing the characteristics of prostate-specific antigens will help in the diagnosis, treatment and monitoring of patients with prostatic pathologies are effective and accurate. The study aims to study the clinical and subclinical characteristics of patients with benign prostatic hyperplasia with lower urinary tract symptoms and investigate the characteristics of the concentration of prostate-specific antigens and some related factors. Subjects and methods: A descriptive cross-sectional study of 90 male patients aged 50 years and older with lower urinary tract symptoms due to benign prostatic hyperplasia. Record clinical features, ultrasound to measure prostatic volume, uroflowmetry, and serum PSA levels to be quantified. Evaluate the correlation between tPSA concentration with some factors such as: age, prostatic volume. Results: The most common age groups were 60 - 69 years old and 70 - 79 years old, patients were admitted to the hospital when they had moderate to severe urinary disorders, the average IPSS score was 19.0 ± 6.9; average QoL score 3.5 ± 1.1. The most common lower urinary tract symptoms were feeling of incomplete urination (86.7%), weak urine stream (84.4%), urinary exertion (81.1%), nocturia (80.0%). The mean prostate volume measured by ultrasound was 36.13 ± 10.86 ml. The mean bladder residual volume was 96.0 ± 47.6 ml, the mean Qmax was 12.7 ± 5.3 ml/s, the mean Qave was 5.6 ± 2.4 ml/s. Most patients had total PSA &lt; 4 ng/ml, accounting for 73.3%. Conclusion: Most of the benign prostatic hyperplasia had total prostate-specific antigen &lt; 4 ng/ml, accounting for 73.3%, only 3.3% of patients exceeded the level &gt; 10 ng/ml. There was no statistically significant relationship between total prostate-specific antigen levels and patient age. Total prostate-specific antigen concentration was related to the patient’s prostate volume (p &lt; 0.05). Key words: prostate, benign prostatic hyperplasia (BPH).

Clinical relevance of prostatic enlargement on transabdominal ultrasound

Background: The prostate enlargement is an important public health problem in the geriatric male patients. The diagnostic procedures of BPH ranges from non-invasive to invasive procedures. This study was undertaken to study the correlation of findings of transabdominal ultrasound with the IPSS scores and QOL scores.Material and methods: A cross sectional study was conducted in the department of radiology on 100 patients attending urology OPD and IPD in a tertiary care hospital in Mangalore. The transabdominal ultrasonography was conducted by an expert sonologist and prostate volume was measured. The data was collected by using a pre-designed proforma and the results were tabulated. Results: Majority of the patients in this study were aged between 60 – 65 years. Increased frequency was most common lower urinary tract symptom observed in this study. There was a statistically significant difference in the grading of prostatic enlargement and IPSS scores. There was no significant difference of grading of prostate volume and Quality of Life scores. Conclusion: This study had shown that, transabdominal ultrasound assessed prostate volume correlates with the IPSS scores.

The Effect of Covid-19 Severity on Lower Urinary Tract Symptoms Manifestations.

Background:The dominant symptoms in the patient with COVID-19 are symptoms of the respiratory organ system such as cough, rhinorrhea, dan shortness of breathing. Nonetheless, some reports found involvement of another organ system, including the gastrointestinal system, cardiovascular system, central nervous system, urinary system, such as lower urinary tract symptoms. Hematuria related to infection of COVID-19 virus on adult and kids were reported. Urinary frequency related to infection of the covid-19 virus was also reported. However, the association between covid-19 infection and lower urinary symptoms was still unknown.ObjectiveThis study aims to identify the effect of covid-19 infection on lower urinary tract symptoms manifestation on the patient with COVID-19 treated in Field Hospital.Methods:The design of this study is cross-sectional. After inclusion and exclusion criteria, the male and female patients were then asked based on question points from the International Prostate Score and latest condition related covid-19. In addition, we statistically analyzed the association and the effect between these two variables.Results:Six hundred and six COVID-19 confirmed patients were included in this study. The most frequent complaints of lower urinary tract symptoms were frequency. The severity of the covid-19 correlates with the lower urinary tracts symptoms score.Conclusion:The most common lower urinary tract symptoms are frequency, urgency, and nocturia. These lower urinary tract symptoms may increase in severity with the severity of the infection from COVID-19. The severity of COVID-19 has a significant effect on the increase in lower urinary tract symptoms.

MP52-14 INITIAL EXPERIENCE USING THE AXONICS SACRAL NEUROMODULATION SYSTEM IN PATIENTS WITH MULTIPLE SCLEROSIS

You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Female Incontinence: Therapy II (MP52)1 Sep 2021MP52-14 INITIAL EXPERIENCE USING THE AXONICS SACRAL NEUROMODULATION SYSTEM IN PATIENTS WITH MULTIPLE SCLEROSIS Anjali Kapur, Annie Chen, Spencer Mossack, Steven Weissbart, and Jason Kim Anjali KapurAnjali Kapur More articles by this author , Annie ChenAnnie Chen More articles by this author , Spencer MossackSpencer Mossack More articles by this author , Steven WeissbartSteven Weissbart More articles by this author , and Jason KimJason Kim More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002082.14AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Voiding dysfunction affects about 90% of multiple sclerosis (MS) patients. Sacral neuromodulation (SNM) is effective for the treatment of overactive (OAB) and underactive (UAB) bladder, the two most common lower urinary tract symptoms in MS. Its utility has been limited by MRI incompatibility, as MS patients often require routine MRIs to evaluate for disease progression. The Axonics r-System is the first FDA-approved SNM device that is 1.5T/3T full-body MRI conditionally safe. This study seeks to investigate symptomatic improvement in MS patients after implantation of the Axonics System. METHODS: All MS patients who presented to our academic institution from December 2019-January 2021 and elected for the Axonics SNM were included. Demographic information and scores on the following validated questionnaires were queried: Urogenital Distress Inventory (UDI-6), Incontinent Impact Questionnaire (IIQ-7), and Global Response Assessment (GRA). RESULTS: Eighteen MS patients (4 male, 14 female) were included: 55.6% relapse-remitting, 33.3% secondary-progressive, 5.6% primary-progressive, 5.6% progressive-relapsing. Average time from surgery to questionnaire was 119 days. On UDI-6, 15 patients reported improvement, 1 reported worsening symptoms, and 2 reported no change. Average UDI-6 scores before and after implantation were 54.6 and 22.8, respectively (p<0.0001). Improvements were significant for all questions under irritative and stress voiding subcategories, and 1 of 2 questions under the obstructive voiding subcategory. On IIQ-7, 15 patients reported improvement and 1 reported worsening symptoms. Two patients did not report incontinence and were excluded. Average IIQ-7 scores before and after implantation were 60.7 and 20.8, respectively (p<0.0001). Improvements were significant for travel, social, and emotional subcategories, but not for physical exercise. The average GRA score was 6.2 corresponding to “moderately improved” symptoms. CONCLUSIONS: The vast majority of MS patients reported significant initial symptomatic improvement in voiding function after implantation of the Axonics System. Future studies are needed to determine the long-term outcomes and durability of this MRI full-body conditionally-safe system. Source of Funding: None © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e935-e935 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Anjali Kapur More articles by this author Annie Chen More articles by this author Spencer Mossack More articles by this author Steven Weissbart More articles by this author Jason Kim More articles by this author Expand All Advertisement Loading ...

Hip and Pelvic Floor Muscle Strength in Women with and without Urgency and Frequency Predominant Lower Urinary Tract Symptoms.

Urgency and frequency are common lower urinary tract symptoms (UF-LUTS) in women. There is limited evidence to guide physical therapist-led treatment. To compare hip and pelvic floor muscle strength between women with and without UF-LUTS. We hypothesized women with UF-LUTS would demonstrate 1) diminished hip external rotator and abductor strength and 2) equivalent pelvic floor strength and diminished endurance compared to controls. A matched case-control study. Women with UF-LUTS (cases) and controls were matched on age, body mass index (BMI), vaginal parity. Examiner measured participants' 1) hip external rotator and abductor strength via dynamometry (maximum voluntary effort against fixed resistance) and 2) pelvic floor muscle strength (peak squeeze pressure) and endurance (squeeze pressure over a 10 second hold) via vaginal manometry. Values compared between cases and controls with paired-sample t-tests (hip) or Wilcoxon signed rank tests (pelvic floor). 21 pairs (42 women): Hip external rotation (67.0 ± 19.0 N vs 83.6 ± 21.5 N; P=0.005) and hip abduction strength (163.1 ± 48.1 N vs 190.1 ± 53.1 N; P=0.04) were significantly lower in cases than controls. There was no significant difference in pelvic floor strength (36.8 ± 19.9 cmH20 vs 41.8 ± 21.0 cmH20; P=0.40) or endurance (234.0 ± 149.6 cmH20*seconds vs 273.4 ± 149.1 cmH20*seconds; P=0.24). Women with UF-LUTS had weaker hip external rotator and abductor muscles, but similar pelvic floor strength and endurance compared to controls. Hip strength may be important to assess in patients with UF-LUTS, further research is needed.

Sex and age differences in lower urinary tract dysfunction in healthy children.

Information about healthy children's urinary tract symptoms is scarce but would be helpful in children with congenital urinary tract conditions. The aim of this study was to develop and evaluate a Lower Urinary Tract Dysfunction (LUTD) questionnaire. A 15-item questionnaire based on definitions by the International Children's Continence Society (ICCS) about urinary tract function, was given to children 4-15years old with no gastrointestinal or urinary tract conditions. The study was approved ethically. The response rate was 82% (311/377), 50% (n=155) were girls. Children were of the age groups 3.5-7years (n=136), 8-12years (n=127), and 13-15years (n=48). More girls than boys reported urinary tract infections (20% vs 3%, p<0.001), while prevalences of incontinence and enuresis were equivalent in both sexes. In the youngest age group, enuresis was the most frequently reported symptom (11%), then daytime incontinence (10%). The older children more frequently reported previous urinary tract infections (12% and 17% in respective groups) and daytime incontinence (9% and 6%, respectively). A LUTD questionnaire is developed and evaluated within this study. Daytime urinary incontinence is the overall most common lower urinary tract symptom and girls report infections more frequently than boys.

Аналіз використання методу анкетування у дослідженні епідеміології стресового нетримання сечі у жінок: вплив на якість життя

The objective: to investigate the epidemiology of the stress urinary incontinence (SUI), and common lower urinary tract symptoms and the related quality of life among women of different age groups of the selected population by the questionnaire method. Materials and methods. Questionnaires of 49 women of all ages, who were not treated for urologic complaints at the time of the survey, were analyzed. The anamnestic part of the Petros questionnaire and short forms Urogenital Distress Inventory (UDI-6) and Incontinence Impact Questionnaire (IIQ-7) were selected for survey. The age distribution is based on qualitative age ranges recommended by WHO. Results. In all, 63% of women surveyed had complaints related with urinary disorders; the most common lower urinary tract symptom was SUI, which worried 41% of all women. The prevalence of SUI among women of different age groups varied: in young and mature women – 35%, significantly increased in middle-aged women and decreased in elderly women. All middle-aged and elderly women had lower urinary tract symptoms. Among the recognized risk factor for SUI was statistically significant cough (p&lt;0.05) with an average association between risk factor and disease. About 61% of patients with urinary incontinence indicated that their symptoms affected quality of life. Conclusions. The analysis of the results of the questionnaire confirmed the feasibility of using UDI-6 and IIQ-7 in epidemiological studies of UI among women. The results of the work performed may be qualified as partial validation of the UDI-6 and IIQ-7 questionnaires in terms of assessing their reliability. Keywords: urinary incontinence among women, stress urinary incontinence among women, lower urinary tract symptoms among women, quality of life, risk factors, questionnaires.

Patient demographic and psychosocial characteristics associated with 30-day recall of self-reported lower urinary tract symptoms.

Measurement of self-reported lower urinary tract symptoms (LUTS) typically uses a recall period, for example, "In the past 30 days…." Compared to averaged daily reports, 30-day recall is generally unbiased, but recall bias varies by item. We examined the associations between personal characteristics (eg, age, symptom bother) and 30-day recall of LUTS using items from the Symptoms of Lower Urinary Tract Dysfunction Research Network Comprehensive Assessment of Self-reported Urinary Symptoms questionnaire. Participants (127 women and 127 men) were recruited from 6 US tertiary care sites. They completed daily assessments for 30 days and a 30-day recall assessment at the end of the study month. For each of the 18 tested items, representing 10 LUTS, the average of the participant's daily responses was modeled as a function of their 30-day recall, the personal characteristic, and the interaction between the 30-day recall and the characteristic in separate general linear regression models, adjusted for sex. Nine items representing 7 LUTS exhibited under- or overreporting (recall bias) for at least 25% of participants. Bias was associated with personal characteristics for six LUTS. Underreporting of incontinence was associated with older age, lower anxiety, and negative affect; overreporting of other LUTS was associated with, symptom bother, symptom variability, anxiety, and depression. We identified under- or overreporting that was associated with personal characteristics for six common LUTS. Some cues (eg, less bother and lower anxiety) were related to recall bias in an unexpected direction. Thus, providers should exercise caution when making judgments about the accuracy of a patient's symptom recall based on patient demographic and psychosocial characteristics.

Les troubles urinaires de la maladie à corps de Lewy. À propos de 19 cas

Lewy Body Dementia (LBD) is a Parkinsonian disorder which often leads to Lower Urinary Tract Symptoms (LUTS), especially an Overactive Bladder (OAB). There have been few LBD related LUTS depictions in the literature, which is why we did this retrospective study. Retrospective single institution study. Nineteen patients with confirmed LBD diagnosis were found, (63% of men, mean age 74 years old). The main symptom was OAB (100% of patients) with frequent stress urinary incontinence (94%) associated with detrusor overactivity (93%) with pressure elevation (79%). Voiding difficulties were found in 16% of medical interviews, and in 53% of urodynamics. In total, 92% of patients complained of constipation, with 44% suffering from fecal incontinence. LBD is characterized by alpha-synuclein aggregates in the cerebral cortex, thus explaining associated cognitive impairment. The most commonly found LUTS is stress incontinence. We also found voiding difficulties in smaller proportion, sometimes associated with prostatism. Topographically, these symptoms could be explained by alpha-synuclein aggregates in the frontal and temporal cortex and the pons. Anorectal disorder and sexual dysfunction were frequently associated. Urological complications are scarce in this population, screening is focused in increasing quality of life, and the possibility to discriminate the different types of Parkinsonisms. OAB is the most common lower urinary tract symptom in LBD often associated with detrusor overactivity, and less frequently voiding difficulties sometimes associated to prostatism. 3.

Outcomes of Non-Invasive laser Therapy for Treatment of Female Stress Urinary Incontinence

Objective: Female stress urinary incontinence (SUI) is common lower urinary tract symptom. It affects the patient's quality of life. This study aimed to evaluate the therapeutic outcomes of non-ablative Er: YAG laser therapy SUI. Study design: This was a prospective non-randomized study for female patients with SUI who were referred to the Urology Department, Sohag University Hospital from March 2017 to June 2018. The study was approved from Sohag University ethics committee. Patients were treated by the clinical protocol for SUI with non-ablative 2940 nm Er: YAG laser. Patients were evaluated at the baseline and every 3 months for 1 year by Validated International Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form (ICIQ-UI SF) Arabic version and the number of daily pads usage .Side effects of the treatment were also reported. Results: Our results included 32female patients. 20 patients (63 %) had SUI while 12 patients (37%) had mixed incontinence. the median duration of symptoms 3 years. with 17 patients (53%) had mild to moderate SUI. There was a significant reduction in the median of daily pads usage from a median of 3to one pad per day at one year with P value (˂ 0.0001). The median (ICIQ-UISF) improved from 12to 5.5at one year (pvalue

A STUDY OF THE PREVALENCE OF VARIOUS LOWER URINARY TRACT SYMPTOMS IN CHILDREN WITH ANALYSIS OF COMORBIDITIES AND UROFLOWMETRY

Background: The International Children’s Continence Society (ICCS) in its standardization article in 2006 and subsequent revision in 2014 have provided guidelines for the diagnosis and management of lower urinary tract symptoms (LUTS) in children. However, the terminologies are still not in common parlance and colloquial terms are being heavily used in India. Objective: The objective of the study was to evaluate the clinical spectrum of LUTS and their comorbidities in children. Materials and Methods: This was an observational cross-sectional study conducted in a tertiary care hospital in Northern India. Children, included in the study, aged 5–12 years who presented with LUTS as defined in the ICCS 2014 updated guidelines. A simultaneous analysis of uroflowmetry graphs was also done in these children and the observations presented in this paper. Results: Enuresis was the most common LUTS with which children presented to the OPD (78% cases) followed by increased frequency of micturition (42%). Among comorbidities, constipation was present in one-third patients of LUTS. Uroflowmetry done in LUTS often yields a normal “bell-shaped” graph in majority of the patients (71%). The study shows that many enuretics have underlying other LUTS and comorbidities that we should be aware of and uroflowmetry, if not coupled with urodynamic studies, is not a game changer. Conclusion: There are not many studies post the standardization of the ICCS conducted in India and this study aims at increasing the awareness of the same among physicians and researchers alike.

Effect of the type of urinary incontinence in the Outcome of laser Therapy for Treatment of Female Stress Urinary Incontinence

Background:Female stress urinary incontinence (SUI) is common lower urinary tract symptom. It affect manywomen especially middle and elderlywomen and about 40% of them have mixed Urinary incontinence(MUI).There are surgical and non-surgical options for treatment of stress urinary incontinence. Lasertherapy is seemed to be a promising minimally invasive option for treatment of female SUI.Objective:To determine the effect of the type of urinary incontinence in laser therapy outcomes.Patients and method(s): A prospective non-randomized study for female patients with SUI who were referredto the Urology Department, Sohag University Hospital from March 2017 to June 2018. The study wasapproved from Sohag University ethics committee. Patients were treated by the clinical protocol for SUIwith non-ablative 2940 nm Er: YAG laser. Patients were evaluated at the baseline and every 3 months for 1year by Validated International Consultation on Incontinence Questionnaire – Urinary Incontinence ShortForm (ICIQ-UI SF) Arabic version and the number of daily pads usage .The patients were classifiedaccording to their type into a pure SUI group and MUI group.Result(s):Our results included 32female patients. 20 patients (63 %) had pure SUI while 12 patients (37%) hadmixed incontinence. the median duration of symptoms 3 years. There was a significant reduction in dailypads usage and ICIQ-UISF score (p value<0001) for both groups with more significant for pure SUI group.No serious side effects were reported.Conclusion:There was a statistically significant effect of the type of UI on laser therapy outcomes with betterresults related to pure SUI.On the other hand, No effect of type ofurinary incontinence on number of lasersessions needed by patients to achieve improvement of their incontinence.

The characters of lower urinary tract symptoms in patients with Parkinson’s disease

Objective To explore the characters of lower urinary tract symptoms (LUTS) in patients with Parkinson’s Disease (PD). Methods From Oct 2013 to Jun 2016, after evaluating of movement disorder by modified Hoehn-Yahr(H-Y) scale and LUTS by international prostate symptom score (IPSS), urodynamic study was performed in PD patients with LUTS. The incidence of every symptom of LUTS, the relationships between the IPSS categories and urodynamic study were analyzed. Results 64 patients (containing 26 male and 38 female) with 40-80(62.7±10.2)years old were included. 2, 4, 30, 19, 12 and 6 patients were belonged to modified H-Y scale 1-4, respectively. Frequency (50 patients, 78.1%) was the most common LUTS, while frequency all day (20 patients, 31.3%) was the most common symptom for the most severe LUTS. IPSS was 17.5±7.8 (4-35) and quality of life was 5.1±0.6 (4-6) for the patients. There was no significant correlation between modified H-Y scale and IPSS (P>0.05). According to the criteria of IPSS, 28 patients (43.8%) only had irritative symptoms, 3 patients (4.7%) only had obstructive symptoms, while 26 patients (40.6%) had mixed symptoms and 7 patients (10.9%) belonged to no one. Urodynamic study showed 11 patients (39.3%) with only irritative symptoms had detrusor overactivity(DO), 6 patients (23.1%) with mixed symptoms had DO+ bladder outlet obstruction (BOO) or DO+ detrusor underactivity, however, there was no one with BOO in the three patients with only obstructive symptoms. Conclusion Frequency was the most common LUTS, while frequency all day was the most common symptom for the most severe LUTS in PD patients. Irritative and mixed symptoms were common in PD patients with LUTS, but the urodynamic results were not consistent with the category of LUTS in most of the patients. LUTS severity was not correlated with movement disorders in PD patients. Key words: Parkinson’s disease; Lower urinary tract symptoms; International prostate symptom score; Urodynamic study

Transobturator midurethral sling: What should patients expect after surgery?

Introduction and hypothesisMidurethral sling (MUS) surgeries are minimally invasive procedures; however, they are not free of postoperative complications. The aim of the study was to assess the occurrence of lower urinary tract symptoms (LUTS) (urgency, nocturia, frequency, splitting/spraying, hesitancy, terminal dribbling, and subjective feeling of postvoid residual) in patients suffering from stress (SUI) or mixed (MUI) urinary incontinence with a predominant SUI component before and after transobturator MUS placement.MethodsThe study group consisted of 88 women with SUI and 18 with MUI who underwent transobturator MUS. All participants were questioned with a self-developed questionnaire before and after surgery regarding the presence of LUTS.ResultsSeven days after surgery, 62 patients (58.5%) noted voiding and postmicturition symptoms, whereas 67 (63.2%) reported problems in storage. The more commonly reported LUTS at week 1 after surgery were urgency (52.8%), splitting/spraying (41.5%), and feeling of incomplete bladder emptying (34.0%). Patients perceived that splitting/spraying was the most bothersome. After 6 months, the most common LUTS reported were hesitancy (14.1%), terminal dribbling (10.4%), and splitting/spraying (9.4%). We noticed a decrease in the number of urgency episodes >2.7 times (p < 0.001) compared with baseline. After 6 months, 97 (91.5%) patients reported the lack of incontinence episodes.ConclusionsA vast majority of patients after MUS suffer from LUTS in the early postoperative period; however, the majority of undesired symptoms resolve spontaneously within the first 6 months postsurgery.

How frequent is nocturia in medical students?

Objective. Nocturia is the most common lower urinary tract symptom and its prevalence increases with age. The frequency of nocturia and related bother are not widely investigated in young adults in the literature. In this study we aimed to investigate frequency, bothersome and relation of nocturia with anxiety in medical students. Methods. A questionnaire consisting of 19 items were sent to medical students via social media by using Survey Monkey TM software. Questions include demographic characteristics, fluid intake habits, voiding symptoms, and bother score related to nocturia. Also, Beck Anxiety Inventory was used to measure level of anxiety. Results. A total of 221 students replied the survey. The mean age was 20.7 ± 2.10. Forty-seven (21.3%) students had nocturia. The rate of nocturia was 27.4% and 13.4% in women and men, respectively ( p =0.011). The frequency of nocturia per night was 80.2%, 17.3% and 2.2% (1, 2, 3 times; respectively). While the frequency of nocturia was found to be related with bother scores there were no relation of gender with degree of bother. Conclusion. Nocturia is frequent in medical students, especially in women. Commonly, nocturia do not cause bother in young adults with one episode and it is not related with anxiety.

An Investigation of Lower Urinary Tract Symptoms in Women Aged 40 and Over.

The objective of this study was to determine lower urinary tract symptoms (LUTS) and associated risk factors in women aged 40 years and over. The study was carried out with a total of 312 women. The data were collected between 1 January 2009 and 30 July 2010. As research instruments, an interview form of 19 questions that questioned personal characteristics and was developed by researchers, and the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) Questionnaire evaluating lower urinary tract symptoms were used. Linear regression analysis was used to detect associated risk factors. The rates of urgency, urinary incontinence, nocturia, and frequency symptoms were 61.5, 52.2, 18.9, and 25%, respectively. BFLUTS total scores increased with age, but the present study has detected no statistically significant differences (P > 0.05). BFLUTS scores of the women demonstrated statistically significant differences according to several risk factors including menopause status (P = 0.03), presence of chronic illness (P = 0.000), medicine use (P = 0.000), recurrent urinary tract infections (P = 0.000), body mass index (BMI) (P = 0.004), delivery number (P = 0.005) and chronic constipation (P = 0.002). Multiple linear regression analysis determined that frequent urinary tract infections, presence of chronic illness, chronic constipation, BMI and number of deliveries were significantly related to LUTS development. The most common LUTS was urgency in women aged 40 years and older. Recurrent urinary tract infection was determined as the most significant risk factor for LUTS, followed by chronic illness, chronic constipation, higher BMI and parity.

A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders.

Parkinson's disease (PD) is a common neurodegenerative disorder, and lower urinary tract (LUT) dysfunction is one of the most common autonomic disorders with an estimated incidence rate of 27-80%. Studies have shown that bladder dysfunction significantly influences quality-of-life (QOL) measures, early institutionalisation, and health economics. We review the pathophysiology of bladder dysfunction in PD, lower urinary tract symptoms (LUTS), objective assessment, and treatment options. In patients with PD, disruption of the dopamine D1-GABAergic direct pathway may lead to LUTS. Overactive bladder (OAB) is the most common LUT symptom in PD patients, and an objective assessment using urodynamics commonly shows detrusor overactivity (DO) in these patients. The post-void residual (PVR) volume is minimal in PD, which differs significantly from multiple system atrophy (MSA) patients who have a more progressive disease that leads to urinary retention. However, subclinical detrusor weakness during voiding may also occur in PD. Regarding bladder management, there are no large, double-blind, prospective studies in this area. It is well recognised that dopaminergic drugs can improve or worsen LUTS in PD patients. Therefore, an add-on therapy with anticholinergics is required. Beta-3 adrenergic agonists are a potential treatment option because there are little to no central cognitive events. Newer interventions, such as deep brain stimulation (DBS), are expected to improve bladder dysfunction in PD. Botulinum toxin injections can be used to treat intractable urinary incontinence in PD. Transurethral resection of the prostate gland (TURP) for comorbid BPH in PD is now recognised to be not contraindicated if MSA is excluded. Collaboration of urologists with neurologists is highly recommended to maximise a patients' bladder-associated QOL. Neurourol. Urodynam. 35:551-563, 2016. © 2015 Wiley Periodicals, Inc.

Prevalence and factor association of premature ejaculation among adult Asian males with lower urinary tract symptoms.

PurposeTo determine the prevalence of premature ejaculation (PE) among adult Asian males presented with lower urinary tract symptoms (LUTS) and characterize its association with other clinical factors.MethodsA cross-sectional study was conducted at a tertiary medical center to determine the prevalence of PE among adult male participants with LUTS during the Annual National Prostate Health Awareness Day. Basic demographic data of the participants were collected. All participants were assessed for the presence and severity of LUTS using the International Prostate Symptom Score (IPSS), and for the presence of PE using the PE diagnostic tool. Digital rectal examination was performed by urologists to obtain prostate size. LUTS was further categorized into severity, storage symptoms (frequency, urgency, and nocturia), and voiding symptoms (weak stream, intermittency, straining, and incomplete emptying) to determine their association with PE. Data were analyzed by comparing the participants with PE (PE diagnostic tool score ≥11) versus those without PE, using the independent t test for continuous data, Mann–Whitney U test for ordinal data, and Chi-square test for nominal data. The statistical significance was set at P < 0.05.ResultsA total of 101 male participants with a mean ± standard deviation age of 60.75 ± 10.32 years were included. Among the participants, 33% had moderate LUTS, and 7% severe LUTS. The most common LUTS was nocturia (33%). The overall prevalence of PE was 27%. There was no significant difference among participants with PE versus those without PE in terms of age, marital status, prostate size, or total IPSS score. However, significant difference between groups was noted on the level of education (Mann–Whitney U, z = −1.993, P = 0.046) where high educational status was noted among participants with PE. Likewise, participants with PE were noted to have more prominent weak stream (Mann–Whitney U, z = −2.126, P = 0.033).ConclusionsAmong the participants consulted with LUTS, 27% have concomitant PE. Educational status seems to have an impact in the self-reporting of PE, which may be due to a higher awareness of participants with higher educational attainment. A significant association between PE and weak stream that was not related to prostate size suggests a neuropathologic association.

Effect of aging on urodynamic parameters in women with stress urinary incontinence.

Stress urinary incontinence (SUI) is one of the most common lower urinary tract symptoms in women. We analyzed age-associated changes in urodynamic parameters in women with SUI. We analyzed the urodynamic study (UDS) results of patients with urodynamically proven SUI between March 2008 and July 2014. In uroflowmetry, maximal flow rate (Qmax), time to Qmax, voided volume, and postvoid residual urine volume (PVR) and filling cystometry data including first, strong desire to void and Valsalva leak point pressure (VLPP) were measured. Also, Qmax and detrusor pressure at Qmax (Pdet@Qmax) of voiding cystometry data were analyzed. The subjects included 776 patients. Among the patients, 151 were withdrawn because of incomplete UDS data or because they met the exclusion criteria. A total of 625 patients enrolled in our study. The mean age of the population was 57.3 years. The mean Qmax, voided volume, voiding time, and PVR were 26.2 mL/s, 292.1 mL, 25.7 s, and 31.7 mL, respectively. Qmax (p=0.001) in uroflowmetry, PVR (p=0.042), first desire to void (p=0.042), Pdet@Qmax (p=0.016), and the bladder contractility index (p=0.046) were significantly different between the age groups. Qmax and Pdet@Qmax were decreased and PVR was increased significantly with age after 60 years. Older women with SUI also have worsened voiding function with age as the results of urodynamic parameters. Specifically, detrusor contractility decreased with age after 60 years.